Literature DB >> 32367068

CDK11 is required for transcription of replication-dependent histone genes.

Pavla Gajdušková1, Igor Ruiz de Los Mozos2,3, Michal Rájecký1, Milan Hluchý1, Jernej Ule2,3, Dalibor Blazek4.   

Abstract

Replication-dependent histones (RDH) are required for packaging of newly synthetized DNA into nucleosomes during the S phase when their expression is highly upregulated. However, the mechanisms of this upregulation in metazoan cells remain poorly understood. Using iCLIP and ChIP-seq, we found that human cyclin-dependent kinase 11 (CDK11) associates with RNA and chromatin of RDH genes primarily in the S phase. Moreover, its amino-terminal region binds FLASH, an RDH-specific 3'-end processing factor, which keeps the kinase on the chromatin. CDK11 phosphorylates serine 2 (Ser2) of the carboxy-terminal domain of RNA polymerase II (RNAPII), which is initiated when RNAPII reaches the middle of RDH genes and is required for further RNAPII elongation and 3'-end processing. CDK11 depletion leads to decreased number of cells in S phase, likely owing to the function of CDK11 in RDH gene expression. Thus, the reliance of RDH expression on CDK11 could explain why CDK11 is essential for the growth of many cancers.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32367068      PMCID: PMC7116321          DOI: 10.1038/s41594-020-0406-8

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  64 in total

Review 1.  The RNA polymerase II carboxy-terminal domain (CTD) code.

Authors:  Dirk Eick; Matthias Geyer
Journal:  Chem Rev       Date:  2013-08-16       Impact factor: 60.622

Review 2.  The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain.

Authors:  Kevin M Harlen; L Stirling Churchman
Journal:  Nat Rev Mol Cell Biol       Date:  2017-03-01       Impact factor: 94.444

Review 3.  The pol II CTD: new twists in the tail.

Authors:  Justyna Zaborowska; Sylvain Egloff; Shona Murphy
Journal:  Nat Struct Mol Biol       Date:  2016-09-06       Impact factor: 15.369

Review 4.  The RNA polymerase II CTD coordinates transcription and RNA processing.

Authors:  Jing-Ping Hsin; James L Manley
Journal:  Genes Dev       Date:  2012-10-01       Impact factor: 11.361

Review 5.  The RNA Polymerase II CTD: The Increasing Complexity of a Low-Complexity Protein Domain.

Authors:  Célia Jeronimo; Pierre Collin; François Robert
Journal:  J Mol Biol       Date:  2016-02-12       Impact factor: 5.469

Review 6.  Splicing and transcription touch base: co-transcriptional spliceosome assembly and function.

Authors:  Lydia Herzel; Diana S M Ottoz; Tara Alpert; Karla M Neugebauer
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-09       Impact factor: 94.444

Review 7.  Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans.

Authors:  Karen Adelman; John T Lis
Journal:  Nat Rev Genet       Date:  2012-10       Impact factor: 53.242

Review 8.  Coupling mRNA processing with transcription in time and space.

Authors:  David L Bentley
Journal:  Nat Rev Genet       Date:  2014-02-11       Impact factor: 53.242

Review 9.  Defining mechanisms that regulate RNA polymerase II transcription in vivo.

Authors:  Nicholas J Fuda; M Behfar Ardehali; John T Lis
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

Review 10.  Transcriptional termination in mammals: Stopping the RNA polymerase II juggernaut.

Authors:  Nick J Proudfoot
Journal:  Science       Date:  2016-06-10       Impact factor: 47.728

View more
  8 in total

Review 1.  Targeting transcription cycles in cancer.

Authors:  Stephin J Vervoort; Jennifer R Devlin; Nicholas Kwiatkowski; Mingxing Teng; Nathanael S Gray; Ricky W Johnstone
Journal:  Nat Rev Cancer       Date:  2021-10-21       Impact factor: 60.716

2.  CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1.

Authors:  Milan Hluchý; Pavla Gajdušková; Igor Ruiz de Los Mozos; Michal Rájecký; Michael Kluge; Benedict-Tilman Berger; Zuzana Slabá; David Potěšil; Elena Weiß; Jernej Ule; Zbyněk Zdráhal; Stefan Knapp; Kamil Paruch; Caroline C Friedel; Dalibor Blazek
Journal:  Nature       Date:  2022-09-14       Impact factor: 69.504

3.  Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffold.

Authors:  Zhengnian Li; Ryosuke Ishida; Yan Liu; Jinhua Wang; Yina Li; Yang Gao; Jie Jiang; Jianwei Che; Jason M Sheltzer; Matthew B Robers; Tinghu Zhang; Kenneth D Westover; Behnam Nabet; Nathanael S Gray
Journal:  Eur J Med Chem       Date:  2022-05-08       Impact factor: 7.088

Review 4.  Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer.

Authors:  Theodora A Constantin; Kyle K Greenland; Anabel Varela-Carver; Charlotte L Bevan
Journal:  Oncogene       Date:  2022-05-14       Impact factor: 8.756

5.  The 3' Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies' association with histone locus bodies.

Authors:  Hidefumi Suzuki; Ryota Abe; Miho Shimada; Tomonori Hirose; Hiroko Hirose; Keisuke Noguchi; Yoko Ike; Nanami Yasui; Kazuki Furugori; Yuki Yamaguchi; Atsushi Toyoda; Yutaka Suzuki; Tatsuro Yamamoto; Noriko Saitoh; Shigeo Sato; Chieri Tomomori-Sato; Ronald C Conaway; Joan W Conaway; Hidehisa Takahashi
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

6.  Oxidative stress induces Ser 2 dephosphorylation of the RNA polymerase II CTD and premature transcription termination.

Authors:  Takashi Yamazaki; Lizhi Liu; James L Manley
Journal:  Transcription       Date:  2021-12-07

7.  ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma.

Authors:  Jianjun Wang; Yuchen Li; Binbin Xu; Jiao Dong; Haiyan Zhao; Dongxia Zhao; Yong Wu
Journal:  Onco Targets Ther       Date:  2021-01-08       Impact factor: 4.147

8.  Functional characterization of the human Cdk10/Cyclin Q complex.

Authors:  Robert Düster; Yanlong Ji; Kuan-Ting Pan; Henning Urlaub; Matthias Geyer
Journal:  Open Biol       Date:  2022-03-16       Impact factor: 6.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.